T2 BIOSYSTEMS INC - COM (TTOO)

CUSIP: 89853L104

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / COM
Total 13F shares
11,375,622
Share change
+551,006
Total reported value
$7,380,419
Put/Call ratio
600%
Price per share
$0.65
Number of holders
41
Value change
-$5,509
Number of buys
25
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 89853L104?
CUSIP 89853L104 identifies TTOO - T2 BIOSYSTEMS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of T2 BIOSYSTEMS INC - COM (TTOO) as of Q1 2020

As of 31 Mar 2020, T2 BIOSYSTEMS INC - COM (TTOO) was held by 41 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,375,622 shares. The largest 10 holders included GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, GAGNON SECURITIES LLC, GSA CAPITAL PARTNERS LLP, GRANAHAN INVESTMENT MANAGEMENT INC/MA, SUSQUEHANNA INTERNATIONAL GROUP, LLP, CITADEL ADVISORS LLC, and BRIDGEWAY CAPITAL MANAGEMENT INC. This page lists 41 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.